Liquidia Technologies, Inc. (NASDAQ:LQDA) Receives $32.38 Consensus Price Target from Brokerages

Liquidia Technologies, Inc. (NASDAQ:LQDA) has received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, seven have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $32.3750.

Several brokerages have recently issued reports on LQDA. Raymond James Financial raised their target price on shares of Liquidia Technologies from $33.00 to $41.00 and gave the stock a “strong-buy” rating in a report on Wednesday, August 13th. HC Wainwright restated a “buy” rating and set a $35.00 target price on shares of Liquidia Technologies in a report on Monday, October 6th. Jefferies Financial Group began coverage on Liquidia Technologies in a report on Friday, August 15th. They set a “buy” rating and a $43.00 target price for the company. Needham & Company LLC upped their target price on Liquidia Technologies from $32.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, August 12th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Liquidia Technologies in a report on Wednesday, October 8th.

Liquidia Technologies Stock Up 1.7%

Shares of Liquidia Technologies stock opened at $23.16 on Monday. The company has a debt-to-equity ratio of 9.84, a quick ratio of 2.41 and a current ratio of 2.49. Liquidia Technologies has a 52-week low of $9.71 and a 52-week high of $29.94. The stock has a market capitalization of $1.99 billion, a price-to-earnings ratio of -13.62 and a beta of 0.15. The company’s 50 day moving average price is $25.05 and its 200-day moving average price is $18.50.

Liquidia Technologies (NASDAQ:LQDA) last issued its earnings results on Tuesday, August 12th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.43) by ($0.06). Liquidia Technologies had a negative return on equity of 232.96% and a negative net margin of 732.17%.The firm had revenue of $8.84 million during the quarter, compared to the consensus estimate of $3.90 million. The business’s revenue for the quarter was up 141.5% compared to the same quarter last year. Equities research analysts forecast that Liquidia Technologies will post -1.51 EPS for the current year.

Insider Activity at Liquidia Technologies

In related news, insider Jason Adair sold 26,057 shares of the company’s stock in a transaction that occurred on Thursday, August 28th. The stock was sold at an average price of $27.86, for a total transaction of $725,948.02. Following the completion of the transaction, the insider owned 171,029 shares in the company, valued at $4,764,867.94. This represents a 13.22% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Roger Jeffs sold 20,261 shares of the company’s stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $23.41, for a total value of $474,310.01. Following the transaction, the chief executive officer owned 1,032,973 shares of the company’s stock, valued at approximately $24,181,897.93. This represents a 1.92% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 881,419 shares of company stock valued at $24,210,818 over the last 90 days. Company insiders own 26.50% of the company’s stock.

Hedge Funds Weigh In On Liquidia Technologies

A number of institutional investors have recently added to or reduced their stakes in LQDA. GAMMA Investing LLC raised its holdings in Liquidia Technologies by 2,342.7% in the first quarter. GAMMA Investing LLC now owns 43,675 shares of the company’s stock worth $644,000 after purchasing an additional 41,887 shares in the last quarter. Rhumbline Advisers raised its holdings in Liquidia Technologies by 6.0% in the first quarter. Rhumbline Advisers now owns 85,463 shares of the company’s stock worth $1,261,000 after purchasing an additional 4,811 shares in the last quarter. SG Americas Securities LLC bought a new position in Liquidia Technologies in the first quarter worth $911,000. Valmark Advisers Inc. raised its holdings in Liquidia Technologies by 7.4% in the first quarter. Valmark Advisers Inc. now owns 18,641 shares of the company’s stock worth $275,000 after purchasing an additional 1,283 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in Liquidia Technologies by 2.9% in the first quarter. Bank of New York Mellon Corp now owns 194,131 shares of the company’s stock worth $2,863,000 after purchasing an additional 5,547 shares in the last quarter. Institutional investors own 64.54% of the company’s stock.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).